...
首页> 外文期刊>Journal of viral hepatitis. >Determination of hepatitis B virus subtypes by an enzyme immunoassay method using monoclonal antibodies to type-specific epitopes of HBsAg.
【24h】

Determination of hepatitis B virus subtypes by an enzyme immunoassay method using monoclonal antibodies to type-specific epitopes of HBsAg.

机译:使用针对HBsAg的特定类型抗原决定簇的单克隆抗体,通过酶免疫测定方法确定乙型肝炎病毒亚型。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We described a Hepatitis B surface antigen (HBsAg) subtyping method based on a commercial enzyme immunoassay (EIA) for detection of HBsAg in which the procedure was modified to include the use of monoclonal antibodies with restricted anti-HBs specificities. This method, which was able to classify HBsAg as: ayw1, ayw2, ayw3, ayw3* (intermediate between ayw3 and ayw4), ayw4, ayr, adw2, adw4 and adr, was compared to counter electrophoresis procedure (CEP) by testing HBsAg positive sera from blood donors included in a prospective national epidemiological survey. Among the 256 HBsAg positive samples tested with both techniques, 111 (43.3%) could not be subtyped with CEP vs 10 (3.9%) with our modified EIA. This difference was related to the serum HBsAg concentration which must be greater than 3000 ng/mL and 100 ng/mL for CEP and EIA, respectively. The results obtained from 145 sera with both methods were concordant. Seventeen out of 18 samples partially classified as ay with CEP were completely determined with EIA. This reliable procedure, derived from commercially available reagents, can be easily used in several applications such as large epidemiologic studies and as a substitute for nucleotide sequencing genotyping which is not adapted for large-scale screening and not applicable on samples from nonviremic hepatitis B virus (HBV) carriers.
机译:我们描述了一种基于商业酶免疫分析(EIA)的乙型肝炎表面抗原(HBsAg)分型方法,用于检测HBsAg,其中该程序经过修改,包括使用具有受限抗HBs特异性的单克隆抗体。该方法能够将HBsAg分为:ayw1,ayw2,ayw3,ayw3 *(在ayw3和ayw4之间的中间体),ayw4,ayr,adw2,adw4和adr,通过测试HBsAg阳性与反电泳程序(CEP)进行了比较。来自全国性流行病学调查的献血者血清。在使用这两种技术测试的256个HBsAg阳性样本中,有111个(43.3%)不能用CEP进行亚型分析,而10个样本(3.9%)不能用我们的改良EIA进行亚型分析。这种差异与血清HBsAg浓度有关,对于CEP和EIA,血清HBsAg浓度必须分别大于3000 ng / mL和100 ng / mL。用两种方法从145个血清中获得的结果是一致的。在EIA中完全确定了18个样本中有17个被CEP部分分类为ay的样本。这种可靠的方法得自市售试剂,可轻松用于多种应用,例如大型流行病学研究,以及替代核苷酸测序基因分型,该基因分型不适用于大规模筛查且不适用于非病毒性乙型肝炎病毒的样品( HBV)携带者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号